231 related articles for article (PubMed ID: 18939816)
1. Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.
Moon SJ; Govindan SV; Cardillo TM; D'Souza CA; Hansen HJ; Goldenberg DM
J Med Chem; 2008 Nov; 51(21):6916-26. PubMed ID: 18939816
[TBL] [Abstract][Full Text] [Related]
2. RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.
Williams CC; Thang SH; Hantke T; Vogel U; Seeberger PH; Tsanaktsidis J; Lepenies B
ChemMedChem; 2012 Feb; 7(2):281-91. PubMed ID: 22144261
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38.
Li QY; Deng XQ; Zu YG; Lv H; Su L; Yao L; Zhang Y; Li L
Eur J Med Chem; 2010 Jul; 45(7):3200-6. PubMed ID: 20392545
[TBL] [Abstract][Full Text] [Related]
4. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
5. CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.
Govindan SV; Cardillo TM; Moon SJ; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2009 Oct; 15(19):6052-61. PubMed ID: 19789330
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues.
Kim DK; Ryu DH; Lee JY; Lee N; Kim YW; Kim JS; Chang K; Im GJ; Kim TK; Choi WS
J Med Chem; 2001 May; 44(10):1594-602. PubMed ID: 11334569
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new camptothecin analogs with improved antitumor activities.
Niizuma S; Tsukazaki M; Suda H; Murata T; Ohwada J; Ozawa S; Fukuda H; Murasaki C; Kohchi M; Morikami K; Yoshinari K; Endo M; Ura M; Tanimura H; Miyazaki Y; Takasuka T; Kawashima A; Nanba E; Nakano K; Ogawa K; Kobayashi K; Okabe H; Umeda I; Shimma N
Bioorg Med Chem Lett; 2009 Apr; 19(7):2018-21. PubMed ID: 19254843
[TBL] [Abstract][Full Text] [Related]
8. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
Leu YL; Chen CS; Wu YJ; Chern JW
J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker.
Zhang X; Tang K; Wang H; Liu Y; Bao B; Fang Y; Zhang X; Lu W
Bioconjug Chem; 2016 May; 27(5):1267-75. PubMed ID: 27070848
[TBL] [Abstract][Full Text] [Related]
10. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.
Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG
J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802
[TBL] [Abstract][Full Text] [Related]
11. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
Wang L; Xie S; Ma L; Chen Y; Lu W
Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of 10-arylcamptothecin derivatives.
Jiao Y; Liu H; Geng M; Duan W
Bioorg Med Chem Lett; 2011 Apr; 21(7):2071-4. PubMed ID: 21333532
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
16. First synthesis of novel spin-labeled derivatives of camptothecin as potential antineoplastic agents.
Liu YQ; Tian X; Yang L; Zhan ZC
Eur J Med Chem; 2008 Nov; 43(11):2610-4. PubMed ID: 18313176
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of A-ring modified hexacyclic analogues of camptothecin.
Li DZ; Wang CY; Pan XD; Liu HY; Fu ZD; Wu S
Yao Xue Xue Bao; 2005 Mar; 40(3):241-7. PubMed ID: 15952596
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of anti-CD123 antibody drug conjugates.
Li B; Zhao W; Zhang X; Wang J; Luo X; Baker SD; Jordan CT; Dong Y
Bioorg Med Chem; 2016 Nov; 24(22):5855-5860. PubMed ID: 27687970
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin.
Zu YG; Li QY; Fu YJ; Wang W
Bioorg Med Chem Lett; 2004 Aug; 14(15):4023-6. PubMed ID: 15225719
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates.
Guo N; Jiang D; Wang L; You X; Teng YO; Yu P
Molecules; 2015 May; 20(5):9393-404. PubMed ID: 26007190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
